ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

NUMI Numinus Wellness Inc

0.58
0.00 (0.00%)
18 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Numinus Wellness Inc TSXV:NUMI TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.58 0.57 0.59 0 01:00:00

Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022

07/10/2022 12:00pm

PR Newswire (Canada)


Numinus Wellness (TSXV:NUMI)
Historical Stock Chart


From Jul 2022 to Jul 2024

Click Here for more Numinus Wellness Charts.

VANCOUVER, BC, Oct. 7, 2022 /CNW/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Payton Nyquvest, Founder and CEO of Numinus, will participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022, at 2:30 p.m. ET / 11:30 a.m. PT.

The discussion will focus on Numinus' recently completed and transformative acquisition of Novamind; the value this acquisition brings to the Company; and key growth opportunities and catalysts for Numinus.

For all investors and other persons interested in participating, please register here.

For more information about the conference, or to schedule a one-on-one meeting with Numinus' management, please send an email to KCSA Strategic Communications NuminusIR@kcsa.com.

About Numinus

Numinus Wellness (TSX: NUMI) helps people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use. At Numinus, we are leading the integration of psychedelic-assisted therapies into mainstream clinical practice and building the foundation for a healthier society.

Learn more at www.numinus.com and follow us on LinkedIn, Facebook, Twitter, and Instagram.

Forward-looking statements

Statements and other information contained in this press release about anticipated future events constitute forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "seek", "anticipate", "believe", "plan", "estimate", "expect" and "intend" and statements that an event "may", "will", "should", "could" or "might" occur or other similar expressions. Forward-looking statements are subject to risks and uncertainties and other factors that could cause actual results to differ materially from those contained in the forward-looking statements. Forward-looking statements are based on estimates and opinions of management at the date the statements are made. The Company does not undertake any obligation to update forward-looking statements even if circumstances or management's estimates or opinions should change except as required by applicable laws. Investors should not place undue reliance on forward-looking statements.

Cision View original content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-a-water-tower-research-fireside-chat-on-thursday-october-13-2022-301643497.html

SOURCE Numinus Wellness Inc.

Copyright 2022 Canada NewsWire

1 Year Numinus Wellness Chart

1 Year Numinus Wellness Chart

1 Month Numinus Wellness Chart

1 Month Numinus Wellness Chart